FDA approves second microbiome-based C. difficile therapy

Nat Rev Drug Discov. 2023 Jun;22(6):436. doi: 10.1038/d41573-023-00081-1.
No abstract available

Publication types

  • News

MeSH terms

  • Clostridioides difficile*
  • Clostridium Infections* / drug therapy
  • Humans
  • Microbiota*